Heidelberg Pharma AG

Share Issue/Capital Change • Jan 9, 2009

News Details

Ad-hoc | 9 January 2009 00:43

WILEX AG: WILEX strengthens German GAAP equity base with capitalization measures

WILEX AG / Miscellaneous

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Munich, 8 January 2009 – The biopharmaceutical company WILEX AG (ISIN
DE0006614720 / Frankfurt Stock Exchange / Prime Standard) has decided to
exercise, in connection with the preparation of the accounts according to
German GAAP (HGB) for the financial year which ended on 30 November 2008,
certain rights under the German Commercial Code (§ 269 HGB) to capitalize
development expenses.

The Executive Management Board passed a resolution to this effect today
which was subsequently approved by the Supervisory Board. The measures
involve the capitalisation of expenses totalling EUR 12.1 million. The
accounts prepared according to German GAAP will therefore include the
increase of EUR 12.1 million resulting from this measure. The accounts
prepared according to IFRS and the equity according to IFRS is not
affected. The company will publish the financial statements for the
financial year 2007/2008 on 19 February 2009.

Contact
Katja Arnold (CIRO)
Manager Investor Relations & Public Relations
WILEX AG
Grillparzerstr. 10
81675 Munich
Germany
Tel.: +49 (0)89-41 31 38-126
Fax: +49 (0)89-41 31 38-99
E-Mail: investors@WILEX.com
Website: http://www.WILEX.com

This communication contains certain forward-looking statements, relating to
the Company’s business, which can be identified by the use of
forward-looking terminology such as 'estimates', 'believes', 'expects',
'may', 'will' 'should' 'future', 'potential' or similar expressions or by
general discussion of strategy, plans or intentions of the Company. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors, which may cause our actual results of operations,
financial condition, performance, or achievements, or industry results, to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, prospective investors and partners are cautioned not
to place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such forward-looking statements to reflect future
events or developments. Given these uncertainties, prospective investors
and partners are cautioned not to place undue reliance on such
forward-looking statements. We disclaim any obligation to update any such
forward-looking statements to reflect future events or developments.
09.01.2009 Financial News transmitted by DGAP

---

Language: English
Issuer: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Phone: +49 (0)89 41 31 38 - 0
Fax: +49 (0)89 41 31 38 - 99
E-mail: info@wilex.com
Internet: www.wilex.com
ISIN: DE0006614720
WKN: 661472
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service

---